Bacteroides thetaiotaomicron

多形拟杆菌

Report date: 2024/01/29 17:45:47

Base Information

Drug NameBacteroides thetaiotaomicron
Drug Alias NameThetanixMRx1233CJRB-203
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionNF-kappa-B-repressing factor inhibitors
TargetsNF-kappa-B-repressing factor
Therapy Area/IndicationsCrohn DiseaseInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator Companies4d Pharma Plc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCrohn DiseaseInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank